Association of Fibrosis With Mortality and Sudden Cardiac Death in Patients With Nonischemic Dilated Cardiomyopathy
The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Abstract
IMPORTANCE: Risk stratification of patients with nonischemic dilated cardiomyopathy is primarily based on left ventricular ejection fraction (LVEF). Superior prognostic factors may improve patient selection for implantable cardioverter-defibrillators (ICDs) and other management decisions. OBJECTIVE: To determine whether myocardial fibrosis (detected by late gadolinium enhancement cardiovascular magnetic resonance [LGE-CMR] imaging) is an independent and incremental predictor of mortality and sudden cardiac death (SCD) in dilated cardiomyopathy. DESIGN, SETTING, AND PATIENTS: Prospective, longitudinal study of 472 patients with dilated cardiomyopathy referred to a UK center for CMR imaging between November 2000 and December 2008 after presence and extent of midwall replacement fibrosis were determined. Patients were followed up through December 2011. MAIN OUTCOME MEASURES: Primary end point was all-cause mortality. Secondary end points included cardiovascular mortality or cardiac transplantation; an arrhythmic composite of SCD or aborted SCD (appropriate ICD shock, nonfatal ventricular fibrillation, or sustained ventricular tachycardia); and a composite of HF death, HF hospitalization, or cardiac transplantation. RESULTS: Among the 142 patients with midwall fibrosis, there were 38 deaths (26.8%) vs 35 deaths (10.6%) among the 330 patients without fibrosis (hazard ratio [HR], 2.96 [95% CI, 1.87-4.69]; absolute risk difference, 16.2% [95% CI, 8.2%-24.2%]; P < .001) during a median follow-up of 5.3 years (2557 patient-years of follow-up). The arrhythmic composite was reached by 42 patients with fibrosis (29.6%) and 23 patients without fibrosis (7.0%) (HR, 5.24 [95% CI, 3.15-8.72]; absolute risk difference, 22.6% [95% CI, 14.6%-30.6%]; P < .001). After adjustment for LVEF and other conventional prognostic factors, both the presence of fibrosis (HR, 2.43 [95% CI, 1.50-3.92]; P < .001) and the extent (HR, 1.11 [95% CI, 1.06-1.16]; P < .001) were independently and incrementally associated with all-cause mortality. Fibrosis was also independently associated with cardiovascular mortality or cardiac transplantation (by fibrosis presence: HR, 3.22 [95% CI, 1.95-5.31], P < .001; and by fibrosis extent: HR, 1.15 [95% CI, 1.10-1.20], P < .001), SCD or aborted SCD (by fibrosis presence: HR, 4.61 [95% CI, 2.75-7.74], P < .001; and by fibrosis extent: HR, 1.10 [95% CI, 1.05-1.16], P < .001), and the HF composite (by fibrosis presence: HR, 1.62 [95% CI, 1.00-2.61], P = .049; and by fibrosis extent: HR, 1.08 [95% CI, 1.04-1.13], P < .001). Addition of fibrosis to LVEF significantly improved risk reclassification for all-cause mortality and the SCD composite (net reclassification improvement: 0.26 [95% CI, 0.11-0.41]; P = .001 and 0.29 [95% CI, 0.11-0.48]; P = .002, respectively). CONCLUSIONS AND RELEVANCE: Assessment of midwall fibrosis with LGE-CMR imaging provided independent prognostic information beyond LVEF in patients with nonischemic dilated cardiomyopathy. The role of LGE-CMR in the risk stratification of dilated cardiomyopathy requires further investigation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2013 ACCF/AHA Guideline for the Management of Heart Failure
Yancy, C. W., Jessup, M., Bozkurt, B., Butler, J., Casey, D. E., Drazner, M. H., Fonarow, G. C., Geraci, S. A., Horwich, T., Januzzi, J. L., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.05.019 · Cited by 12,536
Amiodarone or an Implantable Cardioverter–Defibrillator for Congestive Heart Failure
Bardy, G. H., Lee, K. L., Mark, D. B., Poole, J. E., Packer, D. L., Boineau, R., Domanski, M., Troutman, C., Anderson, J., Johnson, G., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043399 · Cited by 6,552
Pencina, M. J., D' Agostino, R. B., D' Agostino, R. B., & Vasan, R. S. (2008) · Statistics in Medicine · doi:10.1002/sim.2929 · Cited by 6,493
The Effect of Cardiac Resynchronization on Morbidity and Mortality in Heart Failure
Cleland, J. G. F., Daubert, J.-C., Erdmann, E., Freemantle, N., Gras, D., Kappenberger, L., & Tavazzi, L. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050496 · Cited by 6,276
2005 WRITING COMMITTEE MEMBERS, Hunt, S. A., Abraham, W. T., Chin, M. H., Feldman, A. M., Francis, G. S., Ganiats, T. G., Jessup, M., Konstam, M. A., Mancini, D. M., et al. (2009) · Circulation · doi:10.1161/circulationaha.109.192065 · Cited by 3,720
Authors/Task Force Members, Dickstein, K., Cohen-Solal, A., Filippatos, G., McMurray, J. J. V., Ponikowski, P., Poole-Wilson, P. A., Stromberg, A., van Veldhuisen, D. J., Atar, D., et al. (2008) · European Heart Journal · doi:10.1093/eurheartj/ehn309 · Cited by 2,696
Zipes, D. P., Camm, A. J., Borggrefe, M., Buxton, A. E., Chaitman, B., Fromer, M., Gregoratos, G., Klein, G., Myerburg, R. J., Quinones, M. A., et al. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.07.010 · Cited by 1,973
Underlying Causes and Long-Term Survival in Patients with Initially Unexplained Cardiomyopathy
Felker, G. M., Thompson, R. E., Hare, J. M., Hruban, R. H., Clemetson, D. E., Howard, D. L., Baughman, K. L., & Kasper, E. K. (2000) · New England Journal of Medicine · doi:10.1056/nejm200004133421502 · Cited by 1,723
Epstein, A. E., DiMarco, J. P., Ellenbogen, K. A., Estes, N. A. M., Freedman, R. A., Gettes, L. S., Gillinov, A. M., Gregoratos, G., Hammill, S. C., Hayes, D. L., et al. (2013) · Circulation · doi:10.1161/cir.0b013e318276ce9b · Cited by 1,489
Prognostic Importance of Defibrillator Shocks in Patients with Heart Failure
Poole, J. E., Johnson, G. W., Hellkamp, A. S., Anderson, J., Callans, D. J., Raitt, M. H., Reddy, R. K., Marchlinski, F. E., Yee, R., Guarnieri, T., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa071098 · Cited by 1,462
Greenland, P. (2008) · Statistics in Medicine · doi:10.1002/sim.2976 · Cited by 1,300
Cardiovascular Magnetic Resonance, Fibrosis, and Prognosis in Dilated Cardiomyopathy
Assomull, R. G., Prasad, S. K., Lyne, J., Smith, G., Burman, E. D., Khan, M., Sheppard, M. N., Poole-Wilson, P. A., & Pennell, D. J. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.07.049 · Cited by 1,164
Self-citationMcCrohon, J. A., Moon, J. C. C., Prasad, S. K., McKenna, W. J., Lorenz, C. H., Coats, A. J. S., & Pennell, D. J. (2003) · Circulation · doi:10.1161/01.cir.0000078641.19365.4c · Cited by 1,154
Self-citationAssessment of Myocardial Fibrosis With Cardiovascular Magnetic Resonance
Mewton, N., Liu, C. Y., Croisille, P., Bluemke, D., & Lima, J. A. C. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.11.013 · Cited by 984
Idiopathic Dilated Cardiomyopathy
Dec, G. W., & Fuster, V. (1994) · New England Journal of Medicine · doi:10.1056/nejm199412083312307 · Cited by 963
Delayed enhancement cardiovascular magnetic resonance assessment of non-ischaemic cardiomyopathies
Mahrholdt, H., Wagner, A., Judd, R. M., Sechtem, U., & Kim, R. J. (2005) · European Heart Journal · doi:10.1093/eurheartj/ehi258 · Cited by 914
Mechanisms and Models in Heart Failure: The Biomechanical Model and Beyond
Mann, D. L., & Bristow, M. R. (2005) · Circulation · doi:10.1161/circulationaha.104.500546 · Cited by 867
Maceira, A., Prasad, S., Khan, M., & Pennell, D. (2006) · Journal of Cardiovascular Magnetic Resonance · doi:10.1080/10976640600572889 · Cited by 847
Self-citationPrognostic Significance of Myocardial Fibrosis in Hypertrophic Cardiomyopathy
O'Hanlon, R., Grasso, A., Roughton, M., Moon, J. C., Clark, S., Wage, R., Webb, J., Kulkarni, M., Dawson, D., Sulaibeekh, L., et al. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.05.010 · Cited by 825
Self-citationWRITING COMMITTEE MEMBERS, Hundley, W. G., Bluemke, D. A., Finn, J. P., Flamm, S. D., Fogel, M. A., Friedrich, M. G., Ho, V. B., Jerosch-Herold, M., Kramer, C. M., et al. (2010) · Circulation · doi:10.1161/cir.0b013e3181d44a8f · Cited by 821
Wu, K. C., Weiss, R. G., Thiemann, D. R., Kitagawa, K., Schmidt, A., Dalal, D., Lai, S., Bluemke, D. A., Gerstenblith, G., Marbán, E., et al. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.03.018 · Cited by 598
Cost-Effectiveness of Implantable Cardioverter–Defibrillators
Sanders, G. D., Hlatky, M. A., & Owens, D. K. (2005) · New England Journal of Medicine · doi:10.1056/nejmsa051989 · Cited by 547
Rihal, C. S., Nishimura, R. A., Hatle, L. K., Bailey, K. R., & Tajik, A. J. (1994) · Circulation · doi:10.1161/01.cir.90.6.2772 · Cited by 438
Goldberger, J. J., Cain, M. E., Hohnloser, S. H., Kadish, A. H., Knight, B. P., Lauer, M. S., Maron, B. J., Page, R. L., Passman, R. S., Siscovick, D., et al. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.05.003 · Cited by 428
Desai, A. S., Fang, J. C., Maisel, W. H., & Baughman, K. L. (2004) · JAMA · doi:10.1001/jama.292.23.2874 · Cited by 407
Tung, R., Zimetbaum, P., & Josephson, M. E. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.05.058 · Cited by 362
Greenberg, H., Case, R. B., Moss, A. J., Brown, M. W., Carroll, E. R., & Andrews, M. L. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2003.11.038 · Cited by 361
Cardiovascular Magnetic Resonance
Pennell, D. J. (2010) · Circulation · doi:10.1161/circulationaha.108.811547 · Cited by 338
Self-citationGrimm, W., Christ, M., Bach, J., Müller, H.-H., & Maisch, B. (2003) · Circulation · doi:10.1161/01.cir.0000100721.52503.85 · Cited by 321
Iles, L., Pfluger, H., Lefkovits, L., Butler, M. J., Kistler, P. M., Kaye, D. M., & Taylor, A. J. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.06.062 · Cited by 309
Lehrke, S., Lossnitzer, D., Schöb, M., Steen, H., Merten, C., Kemmling, H., Pribe, R., Ehlermann, P., Zugck, C., Korosoglou, G., et al. (2011) · Heart · doi:10.1136/hrt.2010.205542 · Cited by 218
Leyva, F., Taylor, R. J., Foley, P. W. X., Umar, F., Mulligan, L. J., Patel, K., Stegemann, B., Haddad, T., Smith, R. E. A., & Prasad, S. K. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.05.054 · Cited by 205
Self-citationDickstein, K., Cohen-Solal, A., Filippatos, G., McMurray, J. J. V., Ponikowski, P., Poole-Wilson, P. A., Stromberg, A., van Veldhuisen, D. J., Atar, D., Hoes, A. W., et al. (2010) · European Heart Journal · doi:10.1093/eurheartj/ehq027 · Cited by 189
Ezekowitz, J. A., Rowe, B. H., Dryden, D. M., Hooton, N., Vandermeer, B., Spooner, C., & McAlister, F. A. (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-147-4-200708210-00007 · Cited by 172
Risk Stratification for Arrhythmic Sudden Cardiac Death: Identifying the Roadblocks
Goldberger, J. J., Buxton, A. E., Cain, M., Costantini, O., Exner, D. V., Knight, B. P., Lloyd-Jones, D., Kadish, A. H., Lee, B., Moss, A., et al. (2011) · Circulation · doi:10.1161/circulationaha.110.959734 · Cited by 167
de Leeuw, N., Ruiter, D. J., Balk, A. H. M. M., de Jonge, N., Melchers, W. J. G., & Galama, J. M. D. (2001) · Transplant International · doi:10.1007/s001470100339 · Cited by 159
The pathophysiology of advanced heart failure
Baig, M. K., Mahon, N., McKenna, W. J., Caforio, A. L. P., Bonow, R. O., Francis, G. S., & Gheorghiade, M. (1998) · American Heart Journal · doi:10.1016/s0002-8703(98)70252-2 · Cited by 109
Characterising the myocardial interstitial space: the clinical relevance of non-invasive imaging
White, S. K., Sado, D. M., Flett, A. S., & Moon, J. (2012) · Heart · doi:10.1136/heartjnl-2011-301515 · Cited by 97
Electrophysiology Studies in Patients with Dilated Cardiomyopathies
Hsia, H. H., & Marchlinski, F. E. (2002) · Cardiac Electrophysiology Review · doi:10.1023/a:1021109130276 · Cited by 73
Mishkin, J. D., Saxonhouse, S. J., Woo, G. W., Burkart, T. A., Miles, W. M., CONTI, J. B., Schofield, R. S., Sears, S. F., & Aranda, J. M. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.07.039 · Cited by 71
Cygankiewicz, I., Zareba, W., Vazquez, R., Bayes-Genis, A., Pascual, D., Macaya, C., Almendral, J., Fiol, M., Bardaji, A., Gonzalez-Juanatey, J. R., et al. (2009) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2008.11.061 · Cited by 58
Determinants of prognosis in nonischemic dilated cardiomyopathy
Grzybowski, J., Bilińska, Z. T., Rużyłło, W., Kupść, W., Michalak, E., Szcześniewska, D., Popławska, W., & Rydlewska-Sadowska, W. (1996) · Journal of Cardiac Failure · doi:10.1016/s1071-9164(96)80026-1 · Cited by 53
Aleksova, A., Sabbadini, G., Merlo, M., Pinamonti, B., Barbati, G., Zecchin, M., Bussani, R., Silvestri, F., Iorio, A. M., Stolfo, D., et al. (2009) · Journal of Cardiovascular Medicine · doi:10.2459/jcm.0b013e32832bba35 · Cited by 50
Prediction of sudden cardiac death: next steps in pursuit of effective methodology
Stecker, E. C., & Chugh, S. S. (2011) · Journal of Interventional Cardiac Electrophysiology · doi:10.1007/s10840-010-9535-z · Cited by 22
Aleksova, A., Barbati, G., Merlo, M., Stolfo, D., Sabbadini, G., Lenarda, A. D., & Sinagra, G. (2010) · Heart & Lung · doi:10.1016/j.hrtlng.2010.06.001 · Cited by 8
Cited by
McDonagh, T. A., Metra, M., Adamo, M., Gardner, R. S., Baumbach, A., Böhm, M., Burri, H., Butler, J., Čelutkienė, J., Chioncel, O., et al. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehab670 · Cited by 19,442
Self-citation2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure
McDonagh, T. A., Metra, M., Adamo, M., Gardner, R. S., Baumbach, A., Böhm, M., Burri, H., Butler, J., Čelutkienė, J., Chioncel, O., et al. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehab368 · Cited by 13,344
Self-citationNieto, M. A., Huang, R. Y.-J., Jackson, R. A., & Thiery, J. P. (2016) · Cell · doi:10.1016/j.cell.2016.06.028 · Cited by 4,492
Obesity and cardiovascular disease: a scientific statement from the American Heart Association
Powell-Wiley, T. M., Poirier, P., Burke, L. E., Després, J.-P., Gordon-Larsen, P., Lavie, C. J., Lear, S. A., Ndumele, C. E., Neeland, I. J., Sanders, P., et al. (2021) · Circulation · doi:10.1161/cir.0000000000000973 · Cited by 3,691
Zamorano, J. L., Lancellotti, P., Rodriguez Muñoz, D., Aboyans, V., Asteggiano, R., Galderisi, M., Habib, G., Lenihan, D. J., Lip, G. Y. H., Lyon, A. R., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw211 · Cited by 2,544
Self-citation
Metadata
- Authors
- Gulati, A., Jabbour, A., Ismail, T. F., Guha, K., Khwaja, J., Raza, S., Morarji, K., Brown, T. D. H., Ismail, N. A., Dweck, M. R., Di Pietro, E., Roughton, M., Wage, R., Daryani, Y., O’Hanlon, R., Sheppard, M. N., Alpendurada, F., Lyon, A. R., Cook, S. A., Cowie, M. R., Assomull, R. G., Pennell, D. J., & Prasad, S. K.
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2013-03-06
- Volume
- 309
- Issue
- 9
- Pages
- 896
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W2005673278
- Cited by
- 1,179
- References
- 46
- FWCI
- 55.93
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.